GlassScriptPhysician profile
Briana Costello
NPI 1407293426
$28,136.48
in general payments reported to CMS, 2019-2025
51 companies · $260 in 2025
The $260 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,692 · 2020: $4,077 · 2021: $1,857 · 2022: $2,215 · 2023: $12K · 2024: $4,482 · 2025: $260.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $13K · Food and Beverage: $3,089 · Education: $8.90.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $13,197.50 |
| Food and Beverage | $3,089.03 |
| Education | $8.90 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $9,924.84 | 2021-2024 | Ozempic, Wegovy |
| Novartis Pharmaceuticals Corporation | $4,195.44 | 2019-2024 | Leqvio |
| Abbott Laboratories | $1,908.22 | 2019-2023 | Cardiomems |
| Medtronic Vascular, INC. | $1,695.89 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $961.68 | 2019-2024 | Xarelto |
| Argon Medical Devices, INC. | $900.00 | 2023-2024 | Clot Mgmt, Cleaner |
| Boston Scientific Corporation | $840.98 | 2019-2025 | Watchman Flx, Watchman Access System, Lux-Dx Insertable Cardiac Monitor |
| Edwards Lifesciences Corporation | $686.26 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $676.15 | 2019-2025 | Eliquis, Camzyos |
| Amgen INC. | $632.44 | 2019-2025 | Repatha |
| Medtronic, INC. | $462.93 | 2021-2024 | Endurant Iis, Corevalve Evolut R, Ffrangio |
| Terumo Medical Corporation | $426.23 | 2019 | |
| Impulse Dynamics (USA) INC. | $398.19 | 2021-2024 | Optimizer, Optimizer |
| Abiomed | $356.42 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $348.39 | 2019-2024 | Lifevest |
Show all 50 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Briana Costello listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.